UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 126

Sortiert nach

Research Reporting Standards for Radioembolization of Hepatic Malignancies

Journal of vascular and interventional radiology, 2011-03, Vol.22 (3), p.265-278

2011

Link zum Volltext

Verfügbarkeit prüfen

Left ventricular function during and after right ventricular pacing

Journal of the American College of Cardiology, 2004-11, Vol.44 (9), p.1883-1888

2004

Link zum Volltext

Verfügbarkeit prüfen

Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2009-04, Vol.27 (10), p.1653-1659

2009

Link zum Volltext

Verfügbarkeit prüfen

Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)

American journal of clinical oncology, 2007-02, Vol.30 (1), p.45-50

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3793-3803

1999

Link zum Volltext

Verfügbarkeit prüfen

Use of Molecular Imaging to Predict Clinical Outcome in Patients With Rectal Cancer After Preoperative Chemotherapy and Radiation

International journal of radiation oncology, biology, physics, 2009-05, Vol.74 (1), p.55-59

2009

Link zum Volltext

Verfügbarkeit prüfen

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Critical reviews in oncology/hematology, 2001-07, Vol.39 (1), p.181-194

2001

Link zum Volltext

Verfügbarkeit prüfen

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

Cancer, 2002-02, Vol.94 (S4), p.1349-1357

2002

Link zum Volltext

Verfügbarkeit prüfen

The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial

Clinical cancer research, 2009-10, Vol.15 (20), p.6462-6471

2009

Link zum Volltext

Verfügbarkeit prüfen

Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus

Journal of rheumatology, 2008-02, Vol.35 (2), p.230

2008

Link zum Volltext

Verfügbarkeit prüfen

Imaging and dosing in radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin)

Seminars in nuclear medicine, 2004, Vol.34 (1), p.10-13

Spies, Stewart M

2004

Link zum Volltext

Verfügbarkeit prüfen

Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma

Seminars in oncology, 2002-02, Vol.29 (1), p.87-92

2002

Link zum Volltext

Verfügbarkeit prüfen

PET scan assessment of chemotherapy response in metastatic paraganglioma

American journal of clinical oncology, 2003-12, Vol.26 (6), p.563-566

2003

Link zum Volltext

Verfügbarkeit prüfen

Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization

The Journal of nuclear medicine (1978), 2015-08, Vol.56 (8), p.1157-1162

2015

Link zum Volltext

Verfügbarkeit prüfen

Intraarterial Hepatic SPECT/CT Imaging Using ^sup 99m^Tc-Macroaggregated Albumin in Preparation for Radioembolization

The Journal of nuclear medicine (1978), 2015-08, Vol.56 (8), p.1157

2015

Link zum Volltext

Verfügbarkeit prüfen

Intraarterial Hepatic SPECT/CT Imaging Using 99m Tc-Macroaggregated Albumin in Preparation for Radioembolization

Journal of Nuclear Medicine, 2015-08, Vol.56 (8), p.1157-1162

2015

Link zum Volltext

Verfügbarkeit prüfen

Intraarterial Hepatic SPECT/CT Imaging Using sigma up 99m theta c-Macroaggregated Albumin in Preparation for Radioembolization

The Journal of nuclear medicine (1978), 2015-08, Vol.56 (8), p.1157-1157

2015

Link zum Volltext

Verfügbarkeit prüfen

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial

Blood, 2002-06, Vol.99 (12), p.4336-4342

2002

Link zum Volltext

Verfügbarkeit prüfen

Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia

Cancer biotherapy & radiopharmaceuticals, 2003-04, Vol.18 (2), p.165-178

2003

Link zum Volltext

Verfügbarkeit prüfen

Cardiac memory: effects on QT interval and dispersion

Journal of the American College of Cardiology, 2002-03, Vol.39, p.100-100

2002

Link zum Volltext

Verfügbarkeit prüfen

Internal Pair Production of ^sup 90^Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept

The Journal of nuclear medicine (1978), 2011-01, Vol.52 (1), p.72

2011

Link zum Volltext

Verfügbarkeit prüfen

Internal Pair Production of 90 Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept

Journal of Nuclear Medicine, 2011-01, Vol.52 (1), p.72-76

2011

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation

Leukemia & lymphoma, 2013-03, Vol.54 (3), p.497-502

2013

Link zum Volltext

Verfügbarkeit prüfen

W1338 Preliminary Observations of Simultaneous Lactulose Breath Testing (LBT) and Scintigraphy in Controls: SIBO Is Not SIBO

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-683-A-683

2008

Link zum Volltext

Verfügbarkeit prüfen

Bortezomib May Be Safely Combined with Y-90 Ibritumomab Tiuxetan In Patients with Relapsed/Refractory Follicular or Transformed Non-Hodgkin Lymphoma: A Phase I Trial of Combined Induction Therapy and Bortezomib Consolidation

Blood, 2010-11, Vol.116 (21), p.1749-1749

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

Englisch
(126)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Humans
(66)
Life Sciences & Biomedicine
(58)
Science & Technology
(58)
Female
(32)
Middle Aged
(30)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Adult
(26)
Male
(24)
Aged
(21)
Radionuclide Imaging
(20)
Radiology, Nuclear Medicine & Medical Imaging
(18)
Antibodies, Monoclonal - Therapeutic Use
(17)
Oncology
(15)
Radioimmunotherapy
(14)
Treatment Outcome
(12)
Animals
(8)
Combined Modality Therapy
(8)
Iodine Radioisotopes - Therapeutic Use
(8)
Lymphoma, Non-Hodgkin - Radiotherapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Research Reporting Standards for Radioembolization of Hepatic Malignancies

Left ventricular function during and after right ventricular pacing

Yttrium-90 Ibritumomab Tiuxetan Doses Calculated to Deliver up to 15 Gy to Critical Organs May Be Safely Combined With High-Dose BEAM and Autologous Transplantation in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Staging and monitoring of small cell lung cancer using [18F]fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)

Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Use of Molecular Imaging to Predict Clinical Outcome in Patients With Rectal Cancer After Preoperative Chemotherapy and Radiation

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

The Novel Expanded Porphyrin, Motexafin Gadolinium, Combined with [90Y]Ibritumomab Tiuxetan for Relapsed/Refractory Non-Hodgkin's Lymphoma: Preclinical Findings and Results of a Phase I Trial

Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus

Imaging and dosing in radioimmunotherapy with Yttrium 90 ibritumomab tiuxetan (Zevalin)

Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma

PET scan assessment of chemotherapy response in metastatic paraganglioma

Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization

Intraarterial Hepatic SPECT/CT Imaging Using ^sup 99m^Tc-Macroaggregated Albumin in Preparation for Radioembolization

Intraarterial Hepatic SPECT/CT Imaging Using 99m Tc-Macroaggregated Albumin in Preparation for Radioembolization

Intraarterial Hepatic SPECT/CT Imaging Using sigma up 99m theta c-Macroaggregated Albumin in Preparation for Radioembolization

Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial

Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopenia

Cardiac memory: effects on QT interval and dispersion

Internal Pair Production of ^sup 90^Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept

Internal Pair Production of 90 Y Permits Hepatic Localization of Microspheres Using Routine PET: Proof of Concept

Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation

W1338 Preliminary Observations of Simultaneous Lactulose Breath Testing (LBT) and Scintigraphy in Controls: SIBO Is Not SIBO

Bortezomib May Be Safely Combined with Y-90 Ibritumomab Tiuxetan In Patients with Relapsed/Refractory Follicular or Transformed Non-Hodgkin Lymphoma: A Phase I Trial of Combined Induction Therapy and Bortezomib Consolidation

Suchergebnisse filtern